Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential

This publication has 32 references indexed in Scilit:

• The “Funny” Current (I_f) Inhibition by Ivabradine at Membrane Potentials Encompassing Spontaneous Depolarization in Pacemaker Cells
  Molecules, 2012
• Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research
  Osteoarthritis and Cartilage, 2012
• Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic risk
  Cardiovascular Research, 2011
• Structural bases for the different anti-fibrillatory effects of chloroquine and quinidine
  Cardiovascular Research, 2011
• Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
  The Lancet, 2010
• I_f channel inhibitor ivabradine lowers heart rate in mice with enhanced sympathoadrenergic activities
  British Journal of Pharmacology, 2004
• Heart rate as a therapeutic target in heart failure?
  European Heart Journal Supplements, 2003
• Ion Currents Underlying Sinoatrial Node Pacemaker Activity: A New Single Cell Mathematical Model
  Journal of Theoretical Biology, 1996
• Effects of Alinidine, A Novel Bradycardie Agent, on Heart Rate and Blood Pressure in Man
  Journal of Cardiovascular Pharmacology, 1982
• The Preparation of 7-Chloro-4-(4-(N-ethyl-N-β-hydroxyethylamino)-1- methylbutylamino)-quinoline and Related Compounds
  Journal of the American Chemical Society, 1950